169 related articles for article (PubMed ID: 29183020)
1. Clinical Application of Quantitative Foetal Fibronectin for the Prediction of Preterm Birth in Symptomatic Women.
Radford SK; Da Silva Costa F; Araujo Júnior E; Sheehan PM
Gynecol Obstet Invest; 2018; 83(3):285-289. PubMed ID: 29183020
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
Ravi M; Beljorie M; El Masry K
J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
[No Abstract] [Full Text] [Related]
4. Development and validation of a tool incorporating quantitative fetal fibronectin to predict spontaneous preterm birth in symptomatic women.
Kuhrt K; Hezelgrave N; Foster C; Seed PT; Shennan AH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):210-6. PubMed ID: 25964191
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of quantitative fetal fibronectin in predicting spontaneous preterm birth in symptomatic women: A retrospective cohort study.
Nguyen AD; Liu CZ; Lehner C; Amoako AA; Sekar R
Aust N Z J Obstet Gynaecol; 2019 Oct; 59(5):656-661. PubMed ID: 30724331
[TBL] [Abstract][Full Text] [Related]
6. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
[TBL] [Abstract][Full Text] [Related]
7. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
[TBL] [Abstract][Full Text] [Related]
8. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
[TBL] [Abstract][Full Text] [Related]
9. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
[No Abstract] [Full Text] [Related]
10. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic high-risk women.
Tran TL; Jwala S; Terenna C; McGregor A; Das A; Baxter JK; Berghella V
J Matern Fetal Neonatal Med; 2020 Aug; 33(15):2628-2634. PubMed ID: 30612481
[No Abstract] [Full Text] [Related]
11. The effect of blood staining on cervicovaginal quantitative fetal fibronectin concentration and prediction of spontaneous preterm birth.
Hezelgrave NL; Kuhrt K; Cottam K; Seed PT; Tribe RM; Shennan AH
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():103-108. PubMed ID: 27918947
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of quantitative fFn test in predicting the risk of preterm birth.
Centra M; Coata G; Picchiassi E; Alfonsi L; Meniconi S; Bini V; Di Tommaso MR; Cozzolino M; Facchinetti F; Ferrari F; Gervasi MT; Rusconi S; Todros T; Frisina V; Rizzo N; Bisulli M; Di Renzo GC
J Perinat Med; 2017 Jan; 45(1):91-98. PubMed ID: 27049613
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of predictive models for QUiPP App v.2: tool for predicting preterm birth in asymptomatic high-risk women.
Watson HA; Seed PT; Carter J; Hezelgrave NL; Kuhrt K; Tribe RM; Shennan AH
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):348-356. PubMed ID: 31325332
[TBL] [Abstract][Full Text] [Related]
14. Comparison of rapid bedside tests for phosphorylated insulin-like growth factor-binding protein 1 and fetal fibronectin to predict preterm birth.
Tripathi R; Tyagi S; Mala YM; Singh N; Pandey NB; Yadav P
Int J Gynaecol Obstet; 2016 Oct; 135(1):47-50. PubMed ID: 27388033
[TBL] [Abstract][Full Text] [Related]
15. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
Ng VWY; Seto MTY; Lewis H; Cheung KW
BMC Pregnancy Childbirth; 2023 Apr; 23(1):225. PubMed ID: 37016314
[TBL] [Abstract][Full Text] [Related]
16. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin.
Liong S; Di Quinzio MK; Fleming G; Permezel M; Rice GE; Georgiou HM
BJOG; 2015 Feb; 122(3):370-9. PubMed ID: 25056135
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of quantitative fetal fibronectin for spontaneous preterm birth in asymptomatic pregnancies: a systematic literature review and meta-analysis.
Ruma MS; Betts M; Dodman S; Neupane B
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279923. PubMed ID: 37953268
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test.
Ting HS; Chin PS; Yeo GS; Kwek K
Ann Acad Med Singap; 2007 Jun; 36(6):399-402. PubMed ID: 17597963
[TBL] [Abstract][Full Text] [Related]
19. Effect of QUiPP prediction algorithm on treatment decisions in women with a previous preterm birth: a prospective cohort study.
Goodfellow L; Care A; Sharp A; Ivandic J; Poljak B; Roberts D; Alfirevic Z
BJOG; 2019 Dec; 126(13):1569-1575. PubMed ID: 31339631
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of fetal fibronectin testing in clinical practice.
Cornelissen LGH; van Oostrum NHM; van der Woude DAA; Rolf C; Porath MM; Oei SG; van Laar JOEH
J Obstet Gynaecol Res; 2020 Mar; 46(3):405-412. PubMed ID: 31955485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
